Kyoto, Japan

Isao Ohyama


Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 58(Granted Patents)


Location History:

  • Kyoto, JA (1976 - 1977)
  • Osaka, JA (1978)
  • Osaka, JP (1979)

Company Filing History:


Years Active: 1976-1979

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Isao Ohyama: Innovator in Prostaglandin Derivatives

Introduction

Isao Ohyama is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prostaglandin derivatives. With a total of 5 patents to his name, his work has had a considerable impact on medical science.

Latest Patents

Ohyama's latest patents focus on 15-cycloalkyl-prostaglandin derivatives. These compounds exhibit characteristic prostaglandin-like activities and are defined by specific chemical formulas. The invention relates to 15-cycloalkyl-prostaglandins, where various groups and atoms are represented in the formula, allowing for a range of applications in therapeutic settings. The compounds also include cyclodextrin clathrates of such acids and esters, which further enhance their utility in medical applications.

Career Highlights

Throughout his career, Isao Ohyama has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Ono Pharmaceutical Co., Ltd. and Warner-Lambert Company. His work in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

Ohyama has collaborated with several professionals in his field, including Masaki Hayashi and Seiji Kori. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Isao Ohyama's contributions to the field of prostaglandin derivatives highlight his innovative spirit and dedication to medical science. His patents and collaborations reflect a commitment to advancing pharmaceutical research and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…